Pharmacokinetics and Bioequivalence Comparison of 600 mg Single-Dose Linezolid Oral Suspension and Tablet Formulation in Healthy Chinese Subjects
*Corresponding Author:
Copyright: © 2019 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
![image](https://www.omicsonline.org/images/download-pdf.jpg)
Abstract
study heritage: Linezolid is indicated for the treatment of infections resulting from cardio Gram-high-quality bacteria. An oral suspension formula poses an opportunity to strong oral formulations in patients with swallowing difficulties, especially pediatric and geriatric sufferers, or sufferers with feeding tubes